María Victoria
Mateos Manteca
Profesora Titular de Universidad
Medical University of Lublin
Lublin, PoloniaPublicaciones en colaboración con investigadores/as de Medical University of Lublin (4)
2020
-
Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study
Blood Cancer Journal, Vol. 10, Núm. 9
2015
-
Elotuzumab therapy for relapsed or refractory multiple myeloma
New England Journal of Medicine, Vol. 373, Núm. 7, pp. 621-631
2013
-
Persistent overall survival benefit and no increased risk of second malignancies with bortezomib-melphalan-prednisone versus melphalan-prednisone in patients with previously untreated multiple myeloma
Journal of Clinical Oncology, Vol. 31, Núm. 4, pp. 448-455
2008
-
Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma
New England Journal of Medicine, Vol. 359, Núm. 9, pp. 906-917